Evidence map›Paper›PMID 31777594›Full record

ArticleJournal of Cancer2019

Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities.

Li Chu, Jianjiao Ni, Xi Yang, Tong Tong, Jialei Wang, Fang Yin, Ruimin Li, Yida Li, Liqing Zou, Yuan Li and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Li ChuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jianjiao NiDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xi YangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Tong TongDepartment of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jialei WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fang YinCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Ruimin LiDepartment of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yida LiDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Liqing ZouDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yuan LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Congying XieRadiotherapy and Chemotherapy Department, the 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Guodong LiDepartment of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhengfei ZhuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ALKbrain metastaseslung cancerradiographic feature

Identifiers

PMID31777594
PMCPMC6856904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.